Company / Tangible Book Value per Share
Vera Therapeutics, Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$9.41
FY2025
5-year range
$2.38 / $10.43
FY2021-FY2025
Trend
-9.8%
vs FY2024
Sector context
#55 of 209
Health Care
What the data says
At $9.41, Vera Therapeutics, Inc.'s tangible book value per share ranks #55 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 6 years, ranging from $-279.24 in FY2020 to $10.43 in FY2024.
Based on SEC 10-K filings.
9.41 in FY2025 with a 3-year CAGR of +48.1%.
Improved from $2.38 to $9.41 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +48.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-89.9% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 9.8% year-over-year.
- Ranks #55 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.41 | -9.8% |
| FY2024 | $10.43 | +338.1% |
| FY2023 | $2.38 | -17.7% |
| FY2022 | $2.89 | -44.1% |
| FY2021 | $5.18 | +101.9% |
| FY2020 | -$279.24 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026